Pretty much this.
Last year they had to review the clinical data as above.
This year/announcement it's consistent with the TH announcement and it's "regarding its US SMARTCOUGH-C-2 study results and analysis" not a review of the clinical data to find out wtf happened.
Could be grasping at straws, but that'll keep me optimistic, when combined with the Aussie results for the same style trial, till Monday. I can only imagine the cesspit this place will be by then.
- Forums
- ASX - By Stock
- RAP
- Ann: Voluntary Suspension
Ann: Voluntary Suspension, page-59
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 432 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online